Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
They typically have an initial 8 weeks to present a way forward or they have to ask for an extension
Anyone know what the timelines are before we hear an update from Administrators? Anyone know what is typical timelines in a similar situation?
crl123 my circumstances are similar to yours losses wise. However I am fortunate in having my old age pension and a small private pension. We thought things were going well with DDDD with all the connections they were building. I thought we must have good science if people were collaborating with us. Still feel numb really. Good wishes.
Just patiently waiting currently. No expectations but hoping for the best. No too much point debating as there is no way to know what will come of this, or which way it will go. Fingers crossed.
@Sang has his own motives for his non-stop opinionated de-ramping of this share, and its not to help anyone.
Now…in real life. Who would you not trust if you met them?
And who would you rather not know?
Answers probably clear for most people . Many many people seriously personally damaged by this admin. Financially and personally.
Et tu Brute seems to be one person’s methodology.
I prefer the detached but supportive. Staying real. Not proving how wonderful you are whilst others suffer.
The marketplace may often be corrupt and damaging. Does not mean we have to .
Credit to PG and some others here.
Sang, you seem to have been watching the company closely and offering caution to investors . Do you think that DP has misled the market wrt the financial position , as appears to be the case, and if so where is the evidence in your view.
This article below is about M&A trends in biotech. Whenever we've had good news from the scientific front, I was glad not only because of the specific news but mainly because there had been another validation of the 4D platform.
It looks like that a good number of deals in biotech M&A are not only driven by the motivation of the buyer to pounce on late stage assets but on ones at earlier stage as well: in the latter case it's mainly when acquisitions are DRIVEN by technology platforms.
So the sum of the parts in case of 4D should have some value. But, it could well be its platform that gives it that additional edge and value to attract potential bidders, new investors or partners.
Let's just hope there is no fire sale of some sort or (another) incompetence by the administrator or... directors.
https://www.fiercepharma.com/pharma/ma-landscape-tilting-away-late-stage-buys-and-toward-platform-strategy-analysts
A couple of especially relevant extracts:
"The times are changing in the biopharma industry—and it’s happening fast. From 2019 to 2021, for example, total investment in biotechs nearly doubled, which helps explain why the average premium for purchasing biotech assets increased from 51% in 2018 to 71% last year." ...
"The Builder pathway is a late-stage buy to acquire a potentially lucrative asset or assets. An example would be Bristol Myers Squibb’s $13.1 billion purchase of MyoKardia in 2020. The Architect pathway is an earlier-stage acquisition, which involves not only assets, but more importantly, a technology platform. An example here would be Sanofi’s pickup last year of Translate Bio and its mRNA technology for $3.2 billion. "
The Builder (acquisition of an advanced stage asset) and Architect pathways (i.e. earlier stage acquisitions related to a platform) make up about 70% of M&A deals!
Still a zero in my spreadsheet but allowing room for a positive outcome.
I would like to thank you for saving some of my investment I sold most of my 4d shares at 37 p which with buying and sell badly was a 70% loss but better than every penny so I agree it is better to here the truth no matter how sh te it may sound at the time
Can you ambulance chasing jerks please see yourself out? I'm not interested on your claims, thanks but no thanks. Let's get some real discussion on this board.
As for Sang, he's the lowest of the low as is masterbates.
D&O covers tends to cover the thongs below:
breach of trust.
breach of duty.
neglect.
error.
misleading statements.
wrongful trading.
The problem being the "small print" - getting a successful claim from the insurer is bloody difficult!
Yes Roache Directors and Officers Insurance. It is designed to cover the company against oversights and errors perpetrated by the "principals" of a company but it will not cover negligence or deliberate actions designed to knowingly defraud shareholders or the company itself. Moreover the cover is unlikley to be significant - the current insurance market is very averse to this type of risk due to the current economic climate and the nervousness of the markets. To give you an idea, my current company, which turns over £45m a year and has an EBIT of circa £20 million - has maximum D&O cover of circa £5m p.a and that covers 7 Directors and members of the Executive Man team and the Directors of over two dozen subsidiaries.
My understanding is directors have to carry significant insurance also
As you may know, a shareholder can sue a company and its owners or directors, for mismanagement of the company, or for dereliction of their fiduciary duties to the company.
Specifically, Directors can be held personally liable based on three fiduciary duties: the duty of care, the duty of loyalty, and the duty of obedience. Unfortunately, many board members seem to be unaware of their fiduciary responsibilities for the organization for which they volunteer.
Masterblast, ref a class action lawsuit and the serious issues you have smelled for sometime. Exactly what do you recommend the lawsuit is based on? Any ideas gratefully recieved.
Do you have content in the link. I cannot access it. Is DDDD mentioned?
Thanks!!
Oh so you are on a crusade to teach us all your version of "the truth" yes? And to what benefit Sang, other than to masssage your own sanctimonious superiority complex?
And please explain the "facts" behind your 11:58 post? As far as I can see it , it is very light on "facts" but full of your own opinion.... yet more moralising self-righteousness.
By all means carry on with your pontification, if it it is good for your ego and conscience. I for one have had enough, so bye bye from me.
I believe in truth Crusty. Regardless of feelings, facts matter.
FT: Hedge funds scoop up biotech stocks after ‘catastrophic’ declines
https://www.ft.com/content/bfd7d96f-2af9-4614-b1eb-78949365de9a
You DDDD investors are still a tad short sighted here.
Let the liquidators make their decision and in the meantime, prepare for your class action lawsuit in response.
I smell serious issues going on and have done for some time.
So Sang as you have told us umpteen times, you are no longer a shareholder in 4D; you have also told us that you do not hold out any hope that 4D will be saved from liquidation and that anyone holding out with any hope is wasting time, effort and emotional energy.
So can I ask why it is you continue to spend so much time posting on the BB? Is it because you are a narcisist and love the sound of your own "voice"? Is it schadenfreude? Or are you simply wallowing in your own self importance?
I have been a supporter of your posts and your arguments in the recent past but your continued interest with 4D and repudiation with anthing remotely positive looks increasingly malign. Why can't you just let it go? Leave those that need it to their hope, remote as it may be and move on man.
The problem is these boards are full of rampers and shorters and not much else.
Phil do you think investors need to make informed decisions?
Do you think limiting posts to those promoting the company and removing posts that point out flaws in the business plan and execution will lead to more informed decisions or less informed decisions?
I agree that MJ has been annoying but he did prompt me at one point to take a closer look at the safety profile of LBPs. For example, were you aware that there are theoretical safety risks in terms of LBPs leading to antibiotic resistant infections? I was able to look into this and conclude that the risks were sufficiently low for 0518 even though it is from a similar species to e coli.
But it goes to show that the issue of the LBPs safety profile was a bit more complex than the picture given by the Proactive interviews.
You sound like you would fit in very well in North Korea where anyone criticising the status quo would face harsh consequences. The ramping line must be the dominant truth at all times and heretics must be punished.
A bit pathetic, no?
And you say you could not see a scenario where the company went bust. In the worst biotech bear market for many years with companies shutting down left, right and centre and the company with just a few months of cash.
You gaslighted me with your comments about investors not having cool heads and being led by an emotional and fear driven response.
When in fact the rational choice was to break with the feeling of affectionate attachment to the stock, admit to a mistake, salvage what was left and move on.
I got lucky getting out when I did.
Mumbo... not sure what the purpose of your post is.
I 'fall in love' with every company I invest in, when I do full due diligence on it. Everything, including profiles and background of the management team. I do this with every one of my holdings, both on AIM and on Nasdaq. And I never short, as a matter of principle.
I admit I could not see a scenario where BoD allows this outcome. Which is why I invest in a number of companies to manage risk as I never have full visibility. I do still think that science here is very promising.
As to whether you've been shorting here or not: that's between you and your conscience, I dont care. Whenever I see people posting on a board where they are not invested in, and they keep posting for months (and all very bearish) - I assume they are either shorters or have a lot of time on their hands. Again, no need for you to explain yourself here.
Good luck to you. You were right. If you could see this outcome 6 months ago fairbplay to you.
4D Pharma Temporarily halts patient enrollment in clinical trials for cancer, asthma, Parkinson's disease drugs (MT newswires).
Phil - you fell in love with this share and it blinded you to their shortcomings.
I don’t wish this situation on anyone, despite my bearish outlook here, I never shorted 4D.